APTIMA, APTIMA COMBO 2, PACE and TIGRIS are trademarks of Gen-Probe. ULTRIO and PROCLEIX are trademarks of Novartis. All other trademarks are the property of their owners.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations, beliefs,
plans, objectives, assumptions or future events or performance, including
those under the heading "Updated 2007 Financial Guidance," are not
historical facts and are forward-looking statements. These statements are
often, but not always, made through the use of words or phrases such as
believe, will, expect, anticipate, estimate, intend, plan and would. For
example, statements concerning Gen-Probe's financial condition, possible or
expected results of operations, updated financial guidance, regulatory
approvals, future milestone payments, growth opportunities, and plans and
objectives of management are all forward-looking statements.
Forward-looking statements are not guarantees of performance. They involve
known and unknown risks, uncertainties and assumptions that may cause
actual results, levels of activity, performance or achievements to differ
materially from those expressed or implied. Some of these risks,
uncertainties and assumptions include but are not limited to: (i) the risk
that we may not achieve our expected 2007 growth, revenue, earnings or
other financial targets, (ii) the risk that we may not earn or receive
milestone payments from our collaborators, inc
|SOURCE Gen-Probe Incorporated|
Copyright©2007 PR Newswire.
All rights reserved